Tags

Type your tag names separated by a space and hit enter

Treatment of social phobia with antidepressants.
J Clin Psychiatry. 2001; 62 Suppl 1:43-8; discussion 49.JC

Abstract

This article reviews evidence for the utility of antidepressant medications in the treatment of social phobia. Monoamine oxidase inhibitors (MAOIs) were the first antidepressants shown to be effective for social phobia, but dietary restrictions and a relatively high rate of adverse effects often relegate MAOIs to use after other treatments have been found ineffective. Reversible inhibitors of monoamine oxidase (RIMAs) hold promise as safer alternatives to MAOIs, but RIMAs may be less effective and are currently unavailable in the United States. Selective serotonin reuptake inhibitors (SSRIs), of which paroxetine has been the best studied in social phobia to date, have recently emerged as a first-line treatment for the generalized subtype of social phobia. The SSRIs are well tolerated and consistently have been shown to be efficacious in controlled trials.

Authors+Show Affiliations

Anxiety Disorders Clinic, New York State Psychiatric Institute and the College of Physicians and Surgeons of Columbia University, New York 10032, USA. frs1@columbia.edu

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

11206033

Citation

Schneier, F R.. "Treatment of Social Phobia With Antidepressants." The Journal of Clinical Psychiatry, vol. 62 Suppl 1, 2001, pp. 43-8; discussion 49.
Schneier FR. Treatment of social phobia with antidepressants. J Clin Psychiatry. 2001;62 Suppl 1:43-8; discussion 49.
Schneier, F. R. (2001). Treatment of social phobia with antidepressants. The Journal of Clinical Psychiatry, 62 Suppl 1, 43-8; discussion 49.
Schneier FR. Treatment of Social Phobia With Antidepressants. J Clin Psychiatry. 2001;62 Suppl 1:43-8; discussion 49. PubMed PMID: 11206033.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Treatment of social phobia with antidepressants. A1 - Schneier,F R, PY - 2001/2/24/pubmed PY - 2001/3/7/medline PY - 2001/2/24/entrez SP - 43-8; discussion 49 JF - The Journal of clinical psychiatry JO - J Clin Psychiatry VL - 62 Suppl 1 N2 - This article reviews evidence for the utility of antidepressant medications in the treatment of social phobia. Monoamine oxidase inhibitors (MAOIs) were the first antidepressants shown to be effective for social phobia, but dietary restrictions and a relatively high rate of adverse effects often relegate MAOIs to use after other treatments have been found ineffective. Reversible inhibitors of monoamine oxidase (RIMAs) hold promise as safer alternatives to MAOIs, but RIMAs may be less effective and are currently unavailable in the United States. Selective serotonin reuptake inhibitors (SSRIs), of which paroxetine has been the best studied in social phobia to date, have recently emerged as a first-line treatment for the generalized subtype of social phobia. The SSRIs are well tolerated and consistently have been shown to be efficacious in controlled trials. SN - 0160-6689 UR - https://www.unboundmedicine.com/medline/citation/11206033/Treatment_of_social_phobia_with_antidepressants_ L2 - http://www.psychiatrist.com/jcp/article/pages/2001/v62s01/v62s0108.aspx DB - PRIME DP - Unbound Medicine ER -